Home / Cardiovascular system / Candesartan
ATC C09CA06 · Agents Acting On The Renin-Angiotensin System
Candesartan shortage
As of 31 Oct 2026, Candesartan has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Spain, Austria), covering 24 products.
Countries4/5
Products24packs or presentations
Short since31 May 20233.4 years ago
Earliest return30 Nov 2026company estimate
No return date3products
Main reasonActive ingredient shortage
Timeline
GermanyItalySpainAustria
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | CANDESARTAN BASICS 4 mg Tabletten | Basics GmbH | 11 Feb 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 4 mg Tabletten | Basics GmbH | 11 Feb 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 4 mg Tabletten | Basics GmbH | 11 Feb 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | Blopress 16 mg | Cheplapharm Arzneimittel GmbH | 6 Oct 2025 | 5 Oct 2028 | Other Sonstige |
| DE | CANDESARTAN BASICS 16 mg Tabletten | Basics GmbH | 20 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 16 mg Tabletten | Basics GmbH | 20 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 16 mg Tabletten | Basics GmbH | 20 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 8 mg Tabletten | Basics GmbH | 22 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 8 mg Tabletten | Basics GmbH | 22 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 8 mg Tabletten | Basics GmbH | 22 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 32 mg Tabletten | Basics GmbH | 24 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 32 mg Tabletten | Basics GmbH | 24 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 32 mg Tabletten | Basics GmbH | 24 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| IT | CANDESARTAN ZENTIVA | ZENTIVA ITALIA S.R.L. | 31 May 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | CANDESARTAN AUROBINDO | AUROBINDO PHARMA (ITALIA) S.R.L. | 21 Apr 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | CANDESARTAN TEVA ITALIA | TEVA ITALIA S.R.L. | 15 Oct 2026 | 30 Nov 2026 | Manufacturing problem Problemi produttivi |
| IT | CANDESARTAN PENSA announced | TOWA PHARMACEUTICAL S.P.A. | 1 Nov 2026 | 31 Dec 2026 | Manufacturing problem Problemi produttivi |
| ES | BLOPRESS 4 mg COMPRIMIDOS, 14 comprimidos | Cheplapharm Arzneimittel Gmbh | 10 Nov 2025 | not given | Not stated |
| ES | CANDESARTAN VIATRIS 4 MG COMPRIMIDOS EFG, 14 comprimidos | Viatris Limited | 9 Dec 2025 | 6 May 2027 | Not stated |
| ES | CANDESARTAN SUN 32 mg COMPRIMIDOS EFG , 28 comprimidos | Sun Pharmaceutical Industries (Europe) B.V. | 11 Dec 2025 | 30 Jan 2027 | Not stated |
| ES | CANDESARTAN VIATRIS 16 MG COMPRIMIDOS EFG, 28 comprimidos | Viatris Limited | 17 Feb 2026 | 6 May 2027 | Not stated |
| ES | CANDESARTAN VIATRIS 32 MG COMPRIMIDOS EFG, 28 comprimidos | Viatris Limited | 15 Mar 2026 | 6 May 2027 | Not stated |
| ES | CANDESARTAN VIATRIS 8 MG COMPRIMIDOS EFG, 28 comprimidos | Viatris Limited | 23 Jun 2026 | 22 Mar 2027 | Not stated |
| AT | Blopress 32 mg - Tabletten, 28 Stück | Cheplapharm Arzneimittel GmbH | 8 Feb 2026 | 7 Feb 2029 | Commercial decision or withdrawal Vorübergehende Einstellung des Inverkehrbringens |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.